Global Brain Tumor Diagnosis and Therapeutics Market Insights and Forecast to 2031

Report ID: 1156333 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 MRI
        1.2.3 CT Scan
        1.2.4 Tissue Sampling
        1.2.5 PET-CT Scan
        1.2.6 Cerebral Arteriogram
        1.2.7 Lumbar Puncture
        1.2.8 Molecular Testing
        1.2.9 EEG
    1.3 Market by Application
        1.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Surgery
        1.3.3 Radiation Therapy
        1.3.4 Chemotherapy
        1.3.5 Immunotherapy
        1.3.6 Targeted Therapy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Brain Tumor Diagnosis and Therapeutics Market Perspective (2017-2028)
    2.2 Brain Tumor Diagnosis and Therapeutics Growth Trends by Region
        2.2.1 Brain Tumor Diagnosis and Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Brain Tumor Diagnosis and Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Brain Tumor Diagnosis and Therapeutics Market Dynamics
        2.3.1 Brain Tumor Diagnosis and Therapeutics Industry Trends
        2.3.2 Brain Tumor Diagnosis and Therapeutics Market Drivers
        2.3.3 Brain Tumor Diagnosis and Therapeutics Market Challenges
        2.3.4 Brain Tumor Diagnosis and Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue
        3.1.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Brain Tumor Diagnosis and Therapeutics Revenue
    3.4 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio
        3.4.1 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Therapeutics Revenue in 2021
    3.5 Brain Tumor Diagnosis and Therapeutics Key Players Head office and Area Served
    3.6 Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
    3.7 Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Type
    4.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2023-2028)
5 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Application
    5.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size (2017-2028)
    6.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type
        6.2.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2017-2028)
    6.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application
        6.3.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2017-2028)
    6.4 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country
        6.4.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size (2017-2028)
    7.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type
        7.2.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Brain Tumor Diagnosis and Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application
        7.3.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Brain Tumor Diagnosis and Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country
        7.4.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size (2017-2028)
    9.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type
        9.2.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application
        9.3.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country
        9.4.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Company Details
        11.1.2 GE Healthcare Business Overview
        11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
        11.1.4 GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.1.5 GE Healthcare Recent Developments
    11.2 Hitachi
        11.2.1 Hitachi Company Details
        11.2.2 Hitachi Business Overview
        11.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Introduction
        11.2.4 Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.2.5 Hitachi Recent Developments
    11.3 Philips Healthcare
        11.3.1 Philips Healthcare Company Details
        11.3.2 Philips Healthcare Business Overview
        11.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
        11.3.4 Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.3.5 Philips Healthcare Recent Developments
    11.4 Siemens Healthineers
        11.4.1 Siemens Healthineers Company Details
        11.4.2 Siemens Healthineers Business Overview
        11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Introduction
        11.4.4 Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.4.5 Siemens Healthineers Recent Developments
    11.5 Toshiba Corporation
        11.5.1 Toshiba Corporation Company Details
        11.5.2 Toshiba Corporation Business Overview
        11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Introduction
        11.5.4 Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.5.5 Toshiba Corporation Recent Developments
    11.6 Fujifilm Corporation
        11.6.1 Fujifilm Corporation Company Details
        11.6.2 Fujifilm Corporation Business Overview
        11.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Introduction
        11.6.4 Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.6.5 Fujifilm Corporation Recent Developments
    11.7 Shimadzu Corporation
        11.7.1 Shimadzu Corporation Company Details
        11.7.2 Shimadzu Corporation Business Overview
        11.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Introduction
        11.7.4 Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.7.5 Shimadzu Corporation Recent Developments
    11.8 Merck & Co.
        11.8.1 Merck & Co. Company Details
        11.8.2 Merck & Co. Business Overview
        11.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Introduction
        11.8.4 Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.8.5 Merck & Co. Recent Developments
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Details
        11.9.2 AstraZeneca Business Overview
        11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Introduction
        11.9.4 AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.9.5 AstraZeneca Recent Developments
    11.10 Bristol Myer Squibb
        11.10.1 Bristol Myer Squibb Company Details
        11.10.2 Bristol Myer Squibb Business Overview
        11.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Introduction
        11.10.4 Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.10.5 Bristol Myer Squibb Recent Developments
    11.11 Novartis
        11.11.1 Novartis Company Details
        11.11.2 Novartis Business Overview
        11.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Introduction
        11.11.4 Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.11.5 Novartis Recent Developments
    11.12 Roche Diagnostics
        11.12.1 Roche Diagnostics Company Details
        11.12.2 Roche Diagnostics Business Overview
        11.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Introduction
        11.12.4 Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.12.5 Roche Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of MRI
    Table 3. Key Players of CT Scan
    Table 4. Key Players of Tissue Sampling
    Table 5. Key Players of PET-CT Scan
    Table 6. Key Players of Cerebral Arteriogram
    Table 7. Key Players of Lumbar Puncture
    Table 8. Key Players of Molecular Testing
    Table 9. Key Players of EEG
    Table 10. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2017-2022)
    Table 14. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2023-2028)
    Table 16. Brain Tumor Diagnosis and Therapeutics Market Trends
    Table 17. Brain Tumor Diagnosis and Therapeutics Market Drivers
    Table 18. Brain Tumor Diagnosis and Therapeutics Market Challenges
    Table 19. Brain Tumor Diagnosis and Therapeutics Market Restraints
    Table 20. Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Players (2017-2022)
    Table 22. Global Top Brain Tumor Diagnosis and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2021)
    Table 23. Ranking of Global Top Brain Tumor Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
    Table 27. Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2017-2022)
    Table 31. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2023-2028)
    Table 33. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Application (2017-2022)
    Table 35. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Application (2023-2028)
    Table 37. North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 67. GE Healthcare Company Details
    Table 68. GE Healthcare Business Overview
    Table 69. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product
    Table 70. GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. GE Healthcare Recent Developments
    Table 72. Hitachi Company Details
    Table 73. Hitachi Business Overview
    Table 74. Hitachi Brain Tumor Diagnosis and Therapeutics Product
    Table 75. Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Hitachi Recent Developments
    Table 77. Philips Healthcare Company Details
    Table 78. Philips Healthcare Business Overview
    Table 79. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product
    Table 80. Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Philips Healthcare Recent Developments
    Table 82. Siemens Healthineers Company Details
    Table 83. Siemens Healthineers Business Overview
    Table 84. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product
    Table 85. Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Siemens Healthineers Recent Developments
    Table 87. Toshiba Corporation Company Details
    Table 88. Toshiba Corporation Business Overview
    Table 89. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product
    Table 90. Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Toshiba Corporation Recent Developments
    Table 92. Fujifilm Corporation Company Details
    Table 93. Fujifilm Corporation Business Overview
    Table 94. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product
    Table 95. Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. Fujifilm Corporation Recent Developments
    Table 97. Shimadzu Corporation Company Details
    Table 98. Shimadzu Corporation Business Overview
    Table 99. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product
    Table 100. Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. Shimadzu Corporation Recent Developments
    Table 102. Merck & Co. Company Details
    Table 103. Merck & Co. Business Overview
    Table 104. Merck & Co. Brain Tumor Diagnosis and Therapeutics Product
    Table 105. Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. Merck & Co. Recent Developments
    Table 107. AstraZeneca Company Details
    Table 108. AstraZeneca Business Overview
    Table 109. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product
    Table 110. AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 111. AstraZeneca Recent Developments
    Table 112. Bristol Myer Squibb Company Details
    Table 113. Bristol Myer Squibb Business Overview
    Table 114. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product
    Table 115. Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 116. Bristol Myer Squibb Recent Developments
    Table 117. Novartis Company Details
    Table 118. Novartis Business Overview
    Table 119. Novartis Brain Tumor Diagnosis and Therapeutics Product
    Table 120. Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 121. Novartis Recent Developments
    Table 122. Roche Diagnostics Company Details
    Table 123. Roche Diagnostics Business Overview
    Table 124. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product
    Table 125. Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 126. Roche Diagnostics Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Brain Tumor Diagnosis and Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. MRI Features
    Figure 3. CT Scan Features
    Figure 4. Tissue Sampling Features
    Figure 5. PET-CT Scan Features
    Figure 6. Cerebral Arteriogram Features
    Figure 7. Lumbar Puncture Features
    Figure 8. Molecular Testing Features
    Figure 9. EEG Features
    Figure 10. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application: 2021 VS 2028
    Figure 11. Surgery Case Studies
    Figure 12. Radiation Therapy Case Studies
    Figure 13. Chemotherapy Case Studies
    Figure 14. Immunotherapy Case Studies
    Figure 15. Targeted Therapy Case Studies
    Figure 16. Brain Tumor Diagnosis and Therapeutics Report Years Considered
    Figure 17. Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 18. Global Brain Tumor Diagnosis and Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region: 2021 VS 2028
    Figure 20. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players in 2021
    Figure 21. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2021)
    Figure 22. The Top 10 and 5 Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2021
    Figure 23. North America Brain Tumor Diagnosis and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. North America Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 25. North America Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 26. North America Brain Tumor Diagnosis and Therapeutics Market Size Share by Country (2017-2028)
    Figure 27. United States Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Canada Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Europe Brain Tumor Diagnosis and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 30. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 31. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 32. Europe Brain Tumor Diagnosis and Therapeutics Market Size Share by Country (2017-2028)
    Figure 33. Germany Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. France Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. U.K. Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Italy Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Russia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Nordic Countries Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 40. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 41. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 42. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size Share by Region (2017-2028)
    Figure 43. China Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Japan Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. South Korea Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. India Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Australia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Latin America Brain Tumor Diagnosis and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Latin America Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 51. Latin America Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 52. Latin America Brain Tumor Diagnosis and Therapeutics Market Size Share by Country (2017-2028)
    Figure 53. Mexico Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Brazil Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 56. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 57. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 58. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size Share by Country (2017-2028)
    Figure 59. Turkey Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. UAE Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 63. Hitachi Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 64. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 65. Siemens Healthineers Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 66. Toshiba Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 67. Fujifilm Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 68. Shimadzu Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 69. Merck & Co. Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 70. AstraZeneca Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 71. Bristol Myer Squibb Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 72. Novartis Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 73. Roche Diagnostics Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics
Frequently Asked Questions
Brain Tumor Diagnosis and Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Brain Tumor Diagnosis and Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Brain Tumor Diagnosis and Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Brain Implants

Brain Implants market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Organic Cocoa Liquor

Organic Cocoa Liquor market is segmented by Type and by Application. Players, stakeholders, and o ... Read More